Washington [US], February 5 (ANI): A team of researchers have found that an Australian developed neonatal rotavirus vaccine RV3-BB was safe and produced a robust immune response in African babies.
The study has been published in the ‘Lancet Infectious Diseases Journal’.
The immune response generated was similar in the group given a reduced dose of the vaccine compared to the high dose, providing an opportunity to reduce v
Researchers find new rotavirus vaccine to prevent a deadly diarrheal disease from birth
